v3.26.1
Unaudited Condensed Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   17,640,328    
Beginning balance at Dec. 31, 2024 $ 9,540 $ 18 $ 303,853 $ (294,331)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of stock from vested restricted stock units (in shares)   229,151    
Issuance of stock under Employee Stock Purchase Plan (in shares)   80,554    
Issuance of stock under Employee Stock Purchase Plan 198   198  
Stock-based compensation 417   417  
Net loss (3,752)     (3,752)
Ending balance (in shares) at Mar. 31, 2025   17,950,033    
Ending balance at Mar. 31, 2025 6,403 $ 18 304,468 (298,083)
Beginning balance (in shares) at Dec. 31, 2024   17,640,328    
Beginning balance at Dec. 31, 2024 $ 9,540 $ 18 303,853 (294,331)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of stock from warrant exercises (in shares) 107,969      
Net loss $ (8,191)      
Ending balance (in shares) at Jun. 30, 2025   21,998,739    
Ending balance at Jun. 30, 2025 21,034 $ 22 323,534 (302,522)
Beginning balance (in shares) at Dec. 31, 2024   17,640,328    
Beginning balance at Dec. 31, 2024 $ 9,540 $ 18 303,853 (294,331)
Ending balance (in shares) at Dec. 31, 2025 22,911,575 22,911,575    
Ending balance at Dec. 31, 2025 $ 17,449 $ 23 331,708 (314,282)
Beginning balance (in shares) at Mar. 31, 2025   17,950,033    
Beginning balance at Mar. 31, 2025 6,403 $ 18 304,468 (298,083)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of stock, net of issuance costs (in shares)   3,852,500    
Issuance of stock, net of issuance costs $ 18,627 $ 4 18,623  
Issuance of stock from warrant exercises (in shares) 107,969 107,969    
Issuance of stock from vested restricted stock units (in shares)   88,129    
Exercise of stock options (in shares)   108    
Stock-based compensation $ 443   443  
Net loss (4,439)     (4,439)
Ending balance (in shares) at Jun. 30, 2025   21,998,739    
Ending balance at Jun. 30, 2025 $ 21,034 $ 22 323,534 (302,522)
Beginning balance (in shares) at Dec. 31, 2025 22,911,575 22,911,575    
Beginning balance at Dec. 31, 2025 $ 17,449 $ 23 331,708 (314,282)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of stock from cashless warrant exercises (in shares)   804,788    
Issuance of stock from cashless warrant exercises 0 $ 1 (1)  
Issuance of stock from vested restricted stock units (in shares)   275,671    
Issuance of stock under Employee Stock Purchase Plan (in shares)   96,023    
Issuance of stock under Employee Stock Purchase Plan 295   295  
Stock-based compensation 655   655  
Net loss (3,967)     (3,967)
Ending balance (in shares) at Mar. 31, 2026   24,088,057    
Ending balance at Mar. 31, 2026 $ 14,432 $ 24 332,657 (318,249)
Beginning balance (in shares) at Dec. 31, 2025 22,911,575 22,911,575    
Beginning balance at Dec. 31, 2025 $ 17,449 $ 23 331,708 (314,282)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of stock from warrant exercises (in shares) 804,788      
Issuance of stock under Employee Stock Purchase Plan (in shares) 96,023      
Exercise of stock options (in shares) 0      
Net loss $ (7,163)      
Ending balance (in shares) at Jun. 30, 2026 24,193,101 24,193,101    
Ending balance at Jun. 30, 2026 $ 12,216 $ 24 333,637 (321,445)
Beginning balance (in shares) at Mar. 31, 2026   24,088,057    
Beginning balance at Mar. 31, 2026 $ 14,432 $ 24 332,657 (318,249)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of stock from warrant exercises (in shares) 0      
Issuance of stock from vested restricted stock units (in shares)   105,044    
Stock-based compensation $ 980   980  
Net loss $ (3,196)     (3,196)
Ending balance (in shares) at Jun. 30, 2026 24,193,101 24,193,101    
Ending balance at Jun. 30, 2026 $ 12,216 $ 24 $ 333,637 $ (321,445)